Empowering Personalized Medicine
GenDAI is an interdisciplinary and intersectoral research and innovation project, strongly based on cross-fertilisation and knowledge sharing among academic and industry players.
GenDAI brings together the combined experience and efforts of 4 leading academic institutions and 2 seasoned SMEs, located in Germany, Ireland and Italy.
GenDAI started in September 2024 and will run until August 2027.
GenDAI addresses key healthcare challenges: the need for more precise, efficient, and personalized diagnostic tools in healthcare and the growing socio-economic burdens associated with ageing population and wide spreading of chronic diseases.
GenDAI seizes multiple opportunities for innovation as current genomic diagnostic tools are limited in accuracy, speed in delivery of results and compliance with healthcare legal requirements.
GenDAI leverages emerging technologies, untapping the potential of metagenomics to deliver powerful clinical analyses and medical diagnoses, while integrating AI techniques with bioinformatics to dramatically improve analyses of complex medical data and diagnostic accuracy and timeliness.
GenDAI will empower further advances in Personalized Medicine, offering the EU healthcare value chain open solutions with digital tools to empower early-stage clinical analyses and support visible progress in health assessment, while reducing the healthcare systems´ reaction time and operational costs.
GenDAI works are focused in developing a comprehensive Diagnostic Platform, innovating in biomarker discovery, ensuring regulatory compliance, patients´ data security, and enhancing user (clinician´s) experience through interactive reporting.